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www.cdatm.orgAbstractObjective: The aim of this study was to determine the etiology and prevalence of pediatric CAP in Beijing using a real-time
polymerase chain reaction (PCR) technique.
Methods: Between February 15, 2011 and January 18, 2012, 371 pediatric patients with CAP were enrolled at Beijing Children's
Hospital. Sixteen respiratory viruses and two bacteria were detected from tracheal aspirate specimens using commercially available
multiplex real-time reverse transcription PCR (RT-PCR) kits.
Results: A single viral pathogen was detected in 35.3% of enrolled patients, multiple viruses in 11.6%, and virus/bacteria co-
infection in 17.8%. In contrast, only 6.5% of patients had a single bacterial pathogen and 2.2%were infected with multiple bacteria.
The etiological agent was unknown for 26.7% of patients. The most common viruses were respiratory syncytial virus (RSV)
(43.9%), rhinovirus (14.8%), parainﬂuenza virus (9.4%), and adenovirus (8.6%). In patients under three years of age, RSV (44.6%),
rhinovirus (12.8%), and Streptococcus pneumoniae (9.9%) were the most frequent pathogens. In children aged 3e7 years, S.
pneumoniae (38.9%), RSV (30.6%), Haemophilus inﬂuenzae (19.4%), and adenovirus (19.4%) were most prevalent. Finally in
children over seven years, RSV (47.3%), S. pneumoniae (41.9%), and rhinovirus (21.5%) infections were most frequent.
Conclusions: Viral pathogens, specifically RSV, were responsible for the majority of CAP in pediatric patients. However, both S.
pneumoniae andH. inﬂuenzae contributed as major causes of disease. Commercially available multiplexing real-time PCR allowed
for rapid detection of the etiological agent.
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The latest report from the World Health Organiza-
tion attributed between 1.6 and 2.2 million deaths in
children under 5-year-old to acute respiratory illness.1
Community-acquired pneumonia (CAP) is a major
cause of morbidity and hospitalization in young chil-
dren worldwide. The annual incidence is 34e40 cases
per 1000 children in Europe and North America.1 The
symptoms and signs of CAP are fever, cough, malaise
and chest pain. The etiological agents of CAP are
varied. Bacterial agents known to cause CAP include
Streptococcus pneumoniae, Haemophilus inﬂuenzae,
Mycoplasma pneumoniae, and Chlamydophila pneu-
moniae.2e4 Viral agents, such as inﬂuenza virus A and
B, respiratory syncytial virus, parainﬂuenza viruses 1,
2, and 3, adenovirus, and rhinovirus are also
common.5e7 CAP can also be caused by emerging
respiratory viruses such as human metapneumovirus,8
human coronaviruses NL639 and HKU1,10 and
human bocavirus11 have been reported as etiological
agents of CAP.
It is currently difficult to reliably identify the
pathogen responsible for causing CAP based on the
clinical signs and symptoms.7 To be successful, most
treatments for CAP need to be initiated within 24e48
hours of infection. Thus, developing rapid diagnostic
tests for viral pathogens associated with CAP is of the
utmost importance. The epidemics and pandemic
caused by the swine influenza A virus (H1N1) infection
in 2009 have also highlighted the necessity of devel-
oping diagnostic tools that are sensitive and rapid tests
for use during ongoing surveillance studies.
The diagnostic methods that are currently used to
detect respiratory infections include rapid antigen tests,
virus culture, enzyme immunoassays, immunofluores-
cence, and conventional reverse transcription
polymerase chain reaction (RT-PCR) assays.12,13 Virus
culture is considered the gold standard because of its
broad applicability and high specificity. However, it is
time-consuming and it takes 7e12 days to obtain a
positive culture. Enzyme immunoassays and immuno-
fluorescence give rapid results, but, their relative lack of
sensitivity and the availability of reactive antisera can be
limiting factors.14 Advances in conventional RT-PCR
and real-time quantitative PCR assays have greatly
facilitated the etiological study of respiratory infections
due to their higher sensitivity and specificity. These as-
says can also reduce labor and cost by detecting more
than one pathogen in a single reaction by using multiple
probes.15 There are several commercial multiplex assays
available; such as xTAG RVP from Luminex,Multicode-PLx RVP from EraGen Biosciences, and
ResPlex II from Qiagen. These assays have been used
for broad spectrum detection of respiratory viruses with
high cost and they are time-consuming.
In this study, the prevalence and causative agents of
CAP in pediatric patients was described using PCR
techniques. Commercial multiplex real-time RT-PCR
kits designed to detect common respiratory pathogens,
including S. pneumoniae, H. inﬂuenzae, inﬂuenza vi-
ruses A (swine lineage influenza A virus H1N1, season
influenza A virus H3N2) and B, respiratory syncytial
virus, parainﬂuenza viruses 1 to 4, adenovirus, rhino-
virus, human metapneumovirus, human coronavirus
(NL63, OC43, 229E and HKU1) and human bocavirus
were used. The viral and bacterial infections associated
with CAP and clinical and the epidemiological char-
acteristics of CAP in a pediatric population were
analyzed in this study.
Materials and methods
Subject enrollment and sampling
Informed consent was obtained from the objects'
parents or guardians. The participants, and their
guardians, received information detailing the purpose
of the study and their right to have any information
determined remain confidential.
Tracheal aspirate specimens were collected from
pediatric patients presenting with CAP at the Beijing
Children's Hospital between February 15, 2011 and
January 18, 2012. The patients were enrolled according
to a set of criteria that included cough, a high fever,
yellow mucus, lung consolidation, the number of white
blood cells >10  109/L or <4  109/L, or one of the
above-mentioned symptoms plus a spot piece shape
shadow by chest X-ray. The samples were collected
and transported to the Institute of Immunization and
Prevention of Beijing Center for Disease Prevention
and Control for viral and bacterial nucleic acid
extraction and detection.
Extraction of total RNA/DNA
The tracheal aspirate specimens were first treated
with an equal volume of Sputasol solution (Oxoid,
Basingstok, UK) in a 37 C water bath for liquefaction.
The total RNA/DNA was then extracted from the
liquefaction sample using the QIAamp Viral RNA
Mini Kit (Qiagen, Hilden, Germany) per the manu-
facturer's instructions. The nucleic acids was stored in
aliquots at 80 C until use.
Table 2
Etiology of CAP in 371 pediatric patients.
Pathogenic agents n Percentage (%)
Bacterial (single) 24 6.5
Bacterial (multiple) 8 2.2
Bacterial and viral 66 17.8
Viral (single) 131 35.3
Viral (multiple) 43 11.6
Unknown 99 26.7
Total 371 100
CAP: community-acquired pneumonia.
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The duplex real-time PCR kit for detecting S.
pneumoniae and H. inﬂuenzae, and the multiplex
combined real-time PCR detection kit for respiratory
viruses were purchased from Jiangsu Uninovo Bio-
logical Technology Co., LTD. The duplex real-time
PCR was performed using the Applied Biosystems
7500 Fast Real-Time PCR System (ABI, California,
USA). The reaction conditions were: initial denatur-
ation at 95 C for 2 min, followed by 40 cycles of
denaturation of 95 C for 10 s and annealing and
extension at 60 C for 50 s. Fam and Hex fluorescence
was acquired at the end of the annealing and extension
step. The multiplex combined Real-time PCR was also
performed using the Applied Biosystems 7500 Fast
Real-Time PCR System (ABI, California, USA). The
reaction conditions were: (1) reverse transcription at
42 C for 10 min, (2) preliminary denaturation at 95 C
for 10 s, and (3) 45 cycles of denaturation of 95 C for
5 s, annealing at 56 C for 50 s, extension at 72 C for
12 s. Fam, Hex, Rox and Cy5 fluorescence was ac-
quired at the end of the annealing step. The results
were analyzed according to the kit user's manuals.
Results
Clinical characteristics of pediatric CAP patients
Between February 15, 2011 and January 18, 2012,
371 pediatric CAP patients from 1 year to 17 years old
were enrolled in this study. CAP patients were strati-
fied into three groups: 242 (65.2%) patients were in the
pre-kindergarten group (3 years), 36 (9.7%) were in
the kindergarten group (3e7 years) and 93 (25.1%)
were in the school-age group (7 years). Of the pa-
tients enrolled, a fever was documented in 52.3% (194/Table 1
Clinical characteristics of pediatric CAP patients.
Time period 3 years 3e7 years
n Fever Sputum and
chest pain
Lung
consolidation
n Fever Sp
ch
Springa 22 10 22 7 10 10
Summerb 9 5 8 3 4 3
Autumnc 74 19 54 5 7 7
Winterd 137 44 97 31 15 12
Total 242 78 181 46 36 32
CAP: community-acquired pneumonia.
a March 1 e May 31, 2011.
b June 1 e August 31, 2011.
c September 1 e November 20, 2011.
d February 15e28, 2011 and December 1, 2011eJanuary 18, 2012.371), 76% presented with sputum and chest pain (282/
371), and 18.6% presented with lung consolidation
(69/371). The clinical characteristics for each age
group are shown in Table 1.
Identification of broad classes of etiological agents
We wanted to determine whether bacterial or viral
agents were responsible for causing the majority of
CAP cases in the enrolled patients. Table 2 shows the
broad category of etiological agents identified in pe-
diatric CAP patients from Beijing Children's Hospital.
Infection by a single bacteria was observed in 6.5%
(n ¼ 24) of the patients, infection by multiple bacteria
was observed in 2.2% of patients (n ¼ 8), infection by
both bacterial and viral agents was observed in 17.8%
of patients (n ¼ 66), infection by a single viral agent
was observed in 35.3% of patients (n ¼ 131), and
finally, infection by multiple viruses was observed in
11.6% of patients (n ¼ 43). In approximately one
quarter (26.7%, n ¼ 99) of the patients the category of
the etiological agent was not identifiable.
We next want to identify the prevalence of specific
viral and/or bacterial pathogens that were contributing
to CAP. Table 3 shows the bacterial and/or viral
pathogens likely to be the causative agent for disease7 years
utum and
est pain
Lung
consolidation
n Fever Sputum and
chest pain
Lung
consolidation
10 1 21 20 19 8
4 0 2 2 1 1
4 1 17 15 13 0
11 2 53 47 39 10
29 4 93 84 72 19
Table 3
Specific bacterial and viral pathogens identified as etiological agents in CAP patients.
Pathogen n Single infection Co-infection with:
Bacteria Virus Bacteria and virus
Bacteria
S. pneumoniae 77 17 8 45 7
H. inﬂuenzae 36 7 8 14 7
Virus
Respiratory syncytial virus 163 84 33 31 15
Rhinovirus 55 15 3 26 11
Parainﬂuenza virus 1, 2, 3, and 4 35a 11 4 12 7
Adenovirus 32 8 1 14 9
Human bocavirus 14 1 0 8 5
Human coronavirus (NL63, OC43, 229E and HKU1) 14 6 2 5 1
Inﬂuenza virus B 7 4 2 1 0
Human metapneumovirus 5 1 0 3 1
Inﬂuenza virus A
Season H3N2 3 1 0 2 0
Swine lineage H1N1 2 0 0 0 2
Total 443 155 e e e
CAP: community-acquired pneumonia.
a One CAP patient was infected by parainﬂuenza virus 1 and 3.
113T.-G. Zhang et al. / Chronic Diseases and Translational Medicine 1 (2015) 110e116identified in the CAP patients. Bacterial infections
accounted for 30.5% (n ¼ 113) of the total CAP cases.
The most prevalent were S. pneumoniae (20.8%;
n ¼ 77) and H. inﬂuenzae (9.7%; n ¼ 36). Of the cases
associated with S. pneumoniae, 77.9% (n ¼ 60) were
co-infected with viruses and/or bacteria. The majority
(n ¼ 45) were viral coinfection. In the CAP cases
associated with H. inﬂuenzae, 80.1% (n ¼ 29) were
coinfections with viruses and/or bacteria. Viral coin-
fection occurred in 14 cases (48.3%).Table 4
Pathogenic agents distribution by age.
Pathogen n
3
Bacteria
S. pneumoniae 77
H. inﬂuenzae 36
Virus
Respiratory syncytial virus 163
Rhinovirus 55
Parainﬂuenza virus 1, 2, 3, and 4 35
Adenovirus 32
Human bocavirus 14
Human coronavirus (NL63, OC43, 229E and HKU1) 14
Inﬂuenza virus B 7
Human metapneumovirus 5
Inﬂuenza virus A
Swine lineage H1N1 2
Season H3N2 3
Total 443In fact, the majority of CAP cases were associated
with viral infection. Viral agents were detected in 330
of the patients (88.9%). As shown in Table 3, the
predominant infection was with respiratory syncytial
virus which accounted for 43.9% (n ¼ 163) of the viral
infections. Of the remaining viruses rhinovirus was
associated with 14.8% (n ¼ 55) of the CAP cases,
parainﬂuenza virus with 9.4% (n ¼ 35), adenovirus
with 8.6% (n ¼ 32), human bocavirus with 3.8%
(n ¼ 14), human coronaviruses (NL63, OC43, 229EAge group
years (n ¼ 242) 3e7 years (n ¼ 36) 7 years (n ¼ 93)
24 14 39
15 7 14
108 11 44
31 4 20
16 6 13
15 7 10
8 1 5
9 2 3
4 0 3
3 0 2
1 0 1
2 0 1
236 52 155
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1.9% (n ¼ 7), and human metapneumovirus with 1.3%
(n ¼ 5). Influenza infections were detected in only five
of the CAP patients. The seasonal influenza (H3N2)
strain was detected in three patients (0.8%) and swine
influenza (H1N1) was detected in two patients (0.5%).
In the majority of inﬂuenza virus B (57.1%), respira-
tory syncytial virus (51.5%), and human coronavirus
(42.9%) infections only a single agent was detected
which was higher than for other viral infections. In
contrast, the four major viral pathogens (respiratory
syncytial virus, rhinovirus, parainﬂuenza virus, and
adenovirus) were detected more frequently in coin-
fections with other bacterial or viral agents. In patients
infected with rhinovirus, parainﬂuenza virus, and
adenovirus a greater percentage of coinfections were
with viruses than bacteria.
Distribution of pathogenic agents according to age
To determine whether the etiological agent for CAP
varied with age, we compared the prevalence of viral
and bacterial pathogens in each age group. Table 4
shows the distribution of each pathogenic agent ac-
cording to CAP patient age. In the pre-kindergarten
group, the most common pathogens were respiratory
syncytial virus (n ¼ 108, 44.6%), rhinovirus (n ¼ 31,
12.8%) and S. pneumoniae (n ¼ 24, 9.9%). In theFig. 1. Seasonal distribution of CAP (community-acquired pneumonia)age
adenovirus, respiratory syncytial virus and parainﬂuenza virus from Februa
each month during the study period are shown on the left-side y-axis.kindergarten group, S. pneumoniae (n ¼ 14, 38.9%),
respiratory syncytial virus (n ¼ 11, 30.6%), H.
inﬂuenzae (n ¼ 7, 19.4%), and adenovirus (n ¼ 7,
19.4%) were the most common infections. Finally, in
the school-age group, respiratory syncytial virus
(n ¼ 44, 47.3%), S. pneumoniae (n ¼ 39, 41.9%), and
rhinovirus (n ¼ 20, 21.5%) accounted for the greatest
number of infections.
Seasonal epidemiology of major pathogenic agents
for CAP patients
To determine whether the etiology of CAP differs by
seasons, the prevalence of each major pathogen was
compared throughout the year. Fig. 1 shows the seasonal
epidemiology for six of pathogenic agents (S. pneumo-
niae, H. inﬂuenzae, rhinovirus, adenovirus, respiratory
syncytial virus, and parainﬂuenza virus) that were iden-
tified in 371 CAP patients over one year from February
2011 to January 2012. The data is reported as the per-
centage of CAP patients each month that tested positive
for the pathogenic agents. Only five patients were
enrolled from July to October 2011, among which three
patients were enrolled in July, two in August, and no
patients in September and October. Overall, respiratory
syncytial virus and S. pneumoniaewere the predominant
pathogenic agents for CAP patients. These pathogens
were detected in the spring, autumn, and winter.nts. Monthly prevalence of S. pneumoniae, H. inﬂuenzae, rhinovirus,
ry 2011 through January 2012. The percent of six pathogens tested in
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observed from December 2011 to January 2012. The
peak incidence of S. pneumoniae was observed in May
2011. The occurrence throughout the other months was
even except for July to October 2011.
Discussion
CAP is the most common infectious disease
occurring in children and a major cause of mortality
among children living in developing countries.1 The
etiological agents are varied but include a wide range
of respiratory viruses and bacteria. Developing a
technique that allows accurate and rapid detection of
CAP etiological agents would be extremely useful for
clinicians during the care of CAP patients and for the
appropriate antimicrobial selection. More effective
CAP treatment could help decrease hospital costs and
the length of a patient's stay in the hospital.
In this study, we used commercially available
multiplex real-time PCR kits to detect respiratory
pathogens in pediatric CAP patients. The kits were
able to detect 16 respiratory viruses and two bacteria.
We compared the specificity and sensitivity of this kit
with singleplex conventional PCR16 and a commercial
multiplex conventional PCR kit (Seeplex® RV15 ACE
Detection kit, Seegene, South Korea) using 73 throat
swab specimens from upper respiratory tract infection
cases. The positive factor numbers of singleplex con-
ventional PCR, conventional multiplex PCR and
multiplex real-time PCR were 56, 41 and 87, respec-
tively (Data not published). The factors detected only
by the multiplex real-time PCR assay were confirmed
using previously published methods.17 Using the
multiplex real-time PCR assay the etiological agents
could be identified within three hours of receiving
the clinical samples. We chose to use the multiplex
assay for its sensitivity, specify, and rapidity of the
results.
Throat swabs and tracheal aspirate specimens were
collected in parallel from 371 CAP patients. The res-
piratory pathogens in 96 pairs of throat swabs and
tracheal aspirate specimens were detected using the
commercial multiplex real-time PCR kits. The Ct
values for hits from tracheal aspirate specimens were
usually lower than that from throat swabs (Data not
published). Similar to previously published work,18
this indicated that viral loads in tracheal aspirate
specimens were higher than in throat swabs. In addi-
tion, throat swabs are commonly used clinically for
identifying respiratory viruses. However, these samplesare not always appropriate for the detection of disease
associated with S. pneumoniae and H. inﬂuenzae which
can be found in healthy carriers. Tracheal aspirate
specimens were chosen for this study to reflect the true
incidence of respiratory pathogens in pediatric CAP
patients in Beijing.
Respiratory syncytial virus is the leading cause of
lower respiratory tract infections in the pediatric pop-
ulation worldwide.19 It is responsible for an estimated
160000 deaths every year worldwide.20 In this study,
43.9% of the CAP patients had detectable RSV, which
was higher than any other pathogen. In fact the inci-
dence of RSV was two times higher than S. pneumo-
niae (n ¼ 77) that was the second leading cause of
CAP. Respiratory syncytial virus was the most frequent
pathogen detected in all three age groups. Rhinovirus is
another frequently detected viral agent that causes
adult acute respiratory infection in temperate regions.21
Likewise, rhinovirus was also detected in this study in
pediatric CAP patients. In this study two viruses that
had recently been associated with CAP, human meta-
pneumovirus and human bocavirus, were also detected
using multiplex real-time PCR.
In CAP associated with S. pneumoniae and H.
inﬂuenzae, there were frequently coinfections with
other bacteria and/or virus. The 78e80% coinfection
rate was higher than that observed in pediatric CAP
patients in Japan.22 Inﬂuenza viruses A and B are
common pathogens associated with respiratory tract
infection. However, in this study, only 12 of 371 CAP
patients had detectable inﬂuenza virus A (n ¼ 5) or B
(n ¼ 7). This rate was much lower than has been re-
ported by the National Surveillance program. These
results indicated that inﬂuenza viruses A and B were
not the main causative pathogens for pediatric CAP
patients in Beijing.
In conclusion, we assessed the viral and bacterial
etiologies of pediatric CAP patients with multiplex
real-time PCR technique and found that respiratory
syncytial virus, followed by S. pneumoniae, rhinovirus,
H. inﬂuenzae, parainﬂuenza virus, and adenovirus were
the main respiratory pathogens for pediatric CAP pa-
tients in Beijing.
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